Galena Biopharma Announces Launch of New Patient Website: NeuVax.com
February 09, 2012 07:05 ET
|
Galena Biopharma, Inc.
Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low-to-Intermediate HER2 Expression with NeuVax Treatment) study now enrolling under an FDA approved...
Diageo -- Video Interview
September 01, 2005 02:24 ET
|
Cantos
LONDON, Sept. 1, 2005 (PRIMEZONE) -- Preliminary results. Indepth interview available now on www.cantos.com with Paul Walsh, Chief Executive, Diageo (LSE:DGE).
- Results & outlook
- US
-...